DHS Demographics | ||||
---|---|---|---|---|
 |  | HP Genotypes | ||
 | Total | 1/1 | 1/2 | 2/2 |
Number | 1208 | 168 | 505 | 535 |
Age (years) | 61.5 ± 9.35 | 62.5 ± 9.36 | 61.2 ± 9.34 | 61.5 ± 9.36 |
Female (%) | 643 (53.2) | 87 (51.8) | 274 (54.3) | 282 (52.7) |
BMI (kg/m2) | 31.8 ± 6.49 | 31.9 ± 6.27 | 32.1 ± 6.81 | 31.4 ± 6.23 |
Affected (%) | 1013 (83.9) | 134 (79.8) | 431 (85.4) | 448 (83.7) |
Diabetes duration (years) | 10.41 ± 7.1 | 10.95 ± 7.9 | 10.15 ± 7.24 | 10.49 ± 6.86 |
Metabolic Syndrome (%) | 1029 (85.2) | 140 (83.3) | 434 (85.9) | 455 (85.1) |
Glucose (mg/dL) | 139.4 ± 55.5 | 139.7 ± 58.8 | 142.3 ± 56.7 | 136.7 ± 53.1 |
HbA1c (%) | 7.29 ± 1.7 | 7.13 ± 1.57 | 7.31 ± 1.78 | 7.32 ± 1.78 |
C-reactive protein (mg/dl) | 0.59 ± 0.97 | 0.54 ± 0.81 | 0.60 ± 1.05 | 0.59 ± 0.94 |
Hypertension (%) | 1025 (84.85) | 141 (83.93) | 422 (83.56) | 462 (86.36) |
Smoking (%) | 708 (58.85) | 96 (57.49) | 285 (56.55) | 327 (61.47) |
Lipid medication (%) | 540 (44.7) | 76 (45.24) | 221 (43.76) | 243 (45.42) |
Anti-hypertensive medication (%) | 747 (61.84) | 101 (60.12) | 324 (64.16) | 322 (60.19) |
CAC | 1662.5 ± 3160.7 | 1679.1 ± 2449.8 | 1607.2 ± 3001.5 | 1708.5 ± 3492.3 |
CarCP | 312.9 ± 672.1 | 276.2 ± 522.5 | 292.8 ± 610.8 | 343.3 ± 762.4 |
AACP | 10949.3 ± 15748.8 | 12628.86 ± 16231.1 | 9781.9 ± 14236.0 | 11458.1 ± 16775.3 |
IMT (mm) | 0.676 ± 0.134 | 0.677 ± 0.136 | 0.665 ± 0.129 | 0.686 ± 0.139 |
Cholesterol (mg/dL) | 186.8 ± 42.4 | 187.5 ± 46.2 | 187.7 ± 43.4 | 185.8 ± 40.3 |
LDL (mg/dL) | 105.1 ± 32.7 | 104.0 ± 35.3 | 103.3 ± 30.8 | 107.1 ± 33.5 |
HDL (mg/dL) | 43.1 ± 12.5 | 43.5 ± 14.4 | 43.3 ± 12.7 | 42.7 ± 11.6 |
Triglycerides (mg/dL) | 201.4 ± 132.1 | 212.8 ± 162.3 | 208.8 ± 133.7 | 190.9 ± 119.2 |
History of CVD (%) | 471 (38.99) | 72 (42.86) | 191 (37.82) | 208 (38.88) |
Non-CVD Mortality (%) | 122 (10.10) | 19 (11.31) | 49 (9.70) | 54 (10.09) |
CVD Mortality (%) | 100 (8.28) | 11 (6.55) | 34 (6.73) | 55 (10.28) |